Tolcapone and fulminant hepatitis
- 19 September 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9132) , 958
- https://doi.org/10.1016/s0140-6736(05)61511-5
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trialNeurology, 1997
- Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatmentNeurology, 1997